756 studies found for:    Erlotinib
Show Display Options
Rank Status Study
1 Terminated Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205
Condition: Ependymoma
Intervention: Drug: Erlotinib
2 Terminated
Has Results
Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
3 Terminated
Has Results
Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma
Condition: Recurrent or Refractory Pediatric Ependymoma
Interventions: Drug: erlotinib;   Drug: etoposide
4 Completed
Has Results
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Pralatrexate Injection;   Drug: Erlotinib;   Dietary Supplement: Vitamin B12;   Dietary Supplement: Folic Acid
5 Completed
Has Results
Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Bevacizumab and Erlotinib
6 Completed Phase II Trial of Erlotinib in Advanced Pancreatic Cancer
Conditions: Cancer;   Pancreas
Intervention: Drug: Erlotinib
7 Active, not recruiting Erlotinib Prior to Surgery in Patients With Head and Neck Cancer
Condition: Head And Neck Cancer
Intervention: Drug: Erlotinib
8 Active, not recruiting
Has Results
Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: Erlotinib hydrochloride
9 Active, not recruiting Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Erlotinib;   Drug: Hydroxychloroquine
10 Completed Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Bevacizumab;   Drug: Erlotinib;   Drug: Capecitabine;   Radiation: Radiation Therapy
11 Completed
Has Results
A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma
Condition: Cancer
Intervention: Drug: Erlotinib
12 Completed Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: Avastin;   Drug: Tarceva
13 Completed
Has Results
Erlotinib in Treating Patients With Advanced Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: OSI-774
14 Active, not recruiting Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Conditions: Squamous Cell Carcinoma;   Non-Small Cell Lung Cancer
Intervention: Drug: Erlotinib + Rosuvastatin
15 Active, not recruiting OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Docetaxel;   Drug: OSI-774;   Drug: Cisplatin
16 Completed
Has Results
Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Condition: Breast Cancer
Interventions: Drug: erlotinib hydrochloride;   Genetic: TUNEL assay;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: liquid chromatography;   Other: mass spectrometry;   Other: matrix-assisted laser desorption ionization mass spectrometry;   Procedure: therapeutic conventional surgery
17 Completed Erlotinib in Higher Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: Erlotinib
18 Completed Ph I Dasatinib + Erlotinib in Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Erlotinib and Dasatinib
19 Recruiting Erlotinib in Combination With Pralatrexate in Advanced Malignancies
Conditions: Advanced Cancers;   Solid Tumors
Interventions: Drug: Erlotinib;   Drug: Pralatrexate
20 Active, not recruiting Erlotinib in Combination With Cetuximab
Condition: Advanced Cancers
Interventions: Drug: Erlotinib;   Drug: Cetuximab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years